Results 151 to 160 of about 6,757 (297)
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
Deep Learning with Dynamically Weighted Loss Function for Sensor-Based Prognostics and Health Management. [PDF]
Rengasamy D +4 more
europepmc +1 more source
Research and Application for Prognostics and Health Management of EMUs
The development of PHM (prognostics and health management) was introduced. The PHM technology system and system architecture for EMUs were put foward based on the research of the functional structure as well as operation and maintenance of EMUs. Based on
CHI Yugan
doaj
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Rotate Vector (RV) Reducer Fault Detection and Diagnosis System: Towards Component Level Prognostics and Health Management (PHM). [PDF]
Rohan A, Raouf I, Kim HS.
europepmc +1 more source
Deployment of prognostics to optimize aircraft maintenance: A literature review
Historic records show that the cost of operating and supporting an aircraft may exceed the initial purchase price as much as ten times. Maintenance, repair and overhaul activities represent around 10-15% of an airlines annual operational costs. Therefore,
Sprong, Jorben (author) +2 more
core +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht +53 more
wiley +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source

